Effects of CYP3A4*22 and POR*28 variations on the pharmacokinetics of tacrolimus in renal transplant recipients: a meta-analysis of 18 observational studies

被引：0
|
作者：
Ze Li
Xiaozhen Wang
Dandan Li
Sheng Cheng
Zhe Li
Heng Guo
Yiwen Dong
Yingming Zheng
Xingang Li
机构：
[1] Beijing Friendship Hospital,Department of Pharmacy
[2] Capital Medical University,Central Laboratory
[3] Xuanwu Hospital,undefined
[4] Capital Medical University,undefined
来源：
BMC Nephrology | / 25卷
关键词：
Meta-analysis; Genetic polymorphisms; Tacrolimus; Pharmacokinetics; Renal transplant recipients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effects of CYP3A4*22 and POR*28 variations on the pharmacokinetics of tacrolimus in renal transplant recipients: a meta-analysis of 18 observational studies
    Li, Ze
    Wang, Xiaozhen
    Li, Dandan
    Cheng, Sheng
    Li, Zhe
    Guo, Heng
    Dong, Yiwen
    Zheng, Yingming
    Li, Xingang
    BMC NEPHROLOGY, 2024, 25 (01)
  • [2] Effects of the CYP3A4*1B Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Adult Renal Transplant Recipients: A Meta-Analysis
    Shi, Wei-Long
    Tang, Hui-Lin
    Zhai, Suo-Di
    PLOS ONE, 2015, 10 (06):
  • [3] ASSOCIATION OF CYP3A4*18B POLYMORPHISMS WITH THE PHARMACOKINETICS OF TACROLIMUS IN CHINESE RENAL TRANSPLANT RECIPIENTS
    Li Danying
    Fang Yun
    Teng Ruichen
    PROGRESS ON POST-GENOME TECHNOLOGIES AND MODERN NATURAL PRODUCTS, 2011, 2011, : 250 - 252
  • [4] Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis
    Zuo, Xiao-cong
    Ng, Chee M.
    Barrett, Jeffrey S.
    Luo, Ai-jing
    Zhang, Bi-kui
    Deng, Chen-hui
    Xi, Lan-yan
    Cheng, Ke
    Ming, Ying-zi
    Yang, Guo-ping
    Pei, Qi
    Zhu, Li-jun
    Yuan, Hong
    Liao, Hai-qiang
    Ding, Jun-jie
    Wu, Di
    Zhou, Ya-nan
    Jing, Ning-ning
    Huang, Zhi-jun
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (05): : 251 - 261
  • [5] Association of CYP3A4*1B genotype with Cyclosporin A pharmacokinetics in renal transplant recipients: A meta-analysis
    Wang, Cai-e
    Lu, Ke-Peng
    Chang, Zhao
    Guo, Meng-Li
    Qiao, Hai-Ling
    GENE, 2018, 664 : 44 - 49
  • [6] The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients
    Zhang, Jing-Jing
    Liu, Shuai-Bing
    Xue, Ling
    Ding, Xiao-Liang
    Zhang, Hua
    Miao, Li-Yan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (09) : 728 - 736
  • [7] Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients
    Roy, Jean Nicholas
    Barama, Azemi
    Poirier, Charles
    Vinet, Bernard
    Roger, Michel
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (09): : 659 - 665
  • [8] Influence of CYP3A4*22 and CYP3A5*3 genetic polymorphisms on tacrolimus pharmacokinetics in adult renal transplant patients
    Salvador, Pilar
    Outeda, Maria
    Pedreira, Isaura
    Fernandez, Constantino
    Alonso, Angel
    Martin, Isabel
    TRANSPLANTATION, 2016, 100 (07) : S709 - S709
  • [9] The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
    Lunde, Ingrid
    Bremer, Sara
    Midtvedt, Karsten
    Mohebi, Beata
    Dahl, Miriam
    Bergan, Stein
    Asberg, Anders
    Christensen, Hege
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (06) : 685 - 693
  • [10] The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
    Ingrid Lunde
    Sara Bremer
    Karsten Midtvedt
    Beata Mohebi
    Miriam Dahl
    Stein Bergan
    Anders Åsberg
    Hege Christensen
    European Journal of Clinical Pharmacology, 2014, 70 : 685 - 693
12345